Coordinated Approach, More Than One Effective Vaccine Likely Needed To Prevent COVID-19, Scientific Leaders Write

NIH: Coordinated strategy to accelerate multiple COVID-19 vaccine candidates is key, NIH experts say
“A harmonized and collaborative approach to the clinical testing, scale-up, and distribution of candidate vaccines to prevent COVID-19 is essential, scientific leaders write in a perspective published [Monday] in Science. As the COVID-19 pandemic continues, government, industry, and academia have introduced a variety of vaccine candidates. The authors [– Francis Collins, director of the NIH; Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) at NIH; Lawrence Corey, professor in the Vaccine and Infectious Disease Division at the Fred Hutchinson Cancer Research Center in Seattle; and John R. Mascola, director of NIAID’s Vaccine Research Center –] note that more than one effective vaccine approach likely will be required to successfully protect the global community from SARS-CoV-2, the virus that causes COVID-19. They describe a strategic approach to research and development that would generate essential data for multiple vaccine candidates in parallel…” (5/11).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.